Brief report: Intravenous and sequential intravenous and oral ciprofloxacin in the treatment of severe infections

The American Journal of Medicine

Volumn 87, Issue 5 SUPPL. 1, 1989, Pages

  Daly, Jennifer S ^a   Worthington, Michael G ^a   Razvi, Syed A ^a   Robillard, Renée ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ADULT; AGED; ANOREXIA; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA; MALE; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; NONHUMAN; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; RASH; URINARY TRACT INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; CIPROFLOXACIN; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMAN; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0024981610     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(89)90066-1     Document Type: Article

References (15)

1. Pharmacokinetics of ciprofloxacin after oral and parenteral administration
2. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers
3. Ciprofloxacin: an update on clinical experience
4. In-vitro activity of the newer quinolones against aerobic bacteria
5. Treatment of serious infections with intravenous ciprofloxacin
6. Use of intravenous ciprofloxacin in difficult-to-treat infections
7. In vitro study with ciprofloxacin interpretive criteria of agar diffusion test according to standards of the NCCLS and DIN
8. Approved Standard: M2-A3
9. Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine
10. An overview of the pharmacology of intravenously administered ciprofloxacin
11. Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin
12. In vitro activity of ciprofloxacin, a new carboxyquinolone antimicrobial agent
13. Mechanisms of action of and resistance to ciprofloxacin
14. Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci
15. The new quinolones and their combinations with other agents for therapy of severe infections